GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » EBITDA Margin %

3D Global Biotech (ROCO:6808) EBITDA Margin % : -146.50% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. 3D Global Biotech's EBITDA for the six months ended in Dec. 2023 was NT$-16.83 Mil. 3D Global Biotech's Revenue for the six months ended in Dec. 2023 was NT$11.49 Mil. Therefore, 3D Global Biotech's EBITDA margin for the quarter that ended in Dec. 2023 was -146.50%.


3D Global Biotech EBITDA Margin % Historical Data

The historical data trend for 3D Global Biotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech EBITDA Margin % Chart

3D Global Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -99.85 -181.25 -323.42 -417.91 -173.73

3D Global Biotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -623.62 -316.11 -507.01 -207.93 -146.50

Competitive Comparison of 3D Global Biotech's EBITDA Margin %

For the Biotechnology subindustry, 3D Global Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3D Global Biotech's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Global Biotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where 3D Global Biotech's EBITDA Margin % falls into.



3D Global Biotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

3D Global Biotech's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-35.846/20.633
=-173.73 %

3D Global Biotech's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-16.825/11.485
=-146.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3D Global Biotech  (ROCO:6808) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


3D Global Biotech EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


3D Global Biotech (ROCO:6808) Business Description

Traded in Other Exchanges
N/A
Address
No.99, Sec. 1, Xintai 5th Rd, 21st Floor -3, Xizhi District, New Taipei, TWN, 221
3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech (ROCO:6808) Headlines

No Headlines